Q1: 2026-04-30 Earnings Summary EPS of $0.36 beats by $0.05  |  Revenue of $2.70B (2.90% Y/Y) beats by $85.52M Baxter International Inc. ( BAX ) Q1 2026 Earnings Call April 30, 2026 8:30 AM EDT Company Participants Kevin Moran - Vice President & Head of Investor Relations Andrew Hider - CEO, President, Interim Group President of Medical Products & Therapies and Director Anita Zielinski - Interim CFO, Senior VP, Chief Accounting Officer & Controller Conference Call Participants Robert Marcus - JPMorgan Chase & Co, Research Division David Roman - Goldman Sachs Group, Inc., Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Vijay Kumar - Evercore ISI Institutional Equities, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Matthew Taylor - Jefferies LLC, Research Division Joanne Wuensch - Citigroup Inc., Research Division Jayson Bedford - Raymond James & Associates, Inc., Research Division Presentation Operator Good morning,…